PolysacDB Lipooligosaccharide 1616

From DrugPedia: A Wikipedia for Drug discovery

Revision as of 06:08, 8 April 2010 by Raghavagps (Talk | contribs)
(diff) ←Older revision | Current revision (diff) | Newer revision→ (diff)
Jump to: navigation, search


Contents

Carbohydrate Name

Lipooligosaccharide

Carbohydrate Class

Lipopolysaccharide

Source Microbe

Moraxella catarrhalis

Basic Structure

LOS consists of an oligosaccharide and lipid A and is similar to the lipopolysaccharide (LPS) of gramnegative enteric pathogens, but it lacks the O-antigenic side chain of repeating units characteristic of classical LPS. The oligosaccharide part consists of the following residues : α-D-Galp-(1-->4)-β-D-Galp-(1-->4)-α-D-Glcp-(1-->2)-β-D-Glcp-(1-->6)-α-D-Glcp [branched to α-D-GlcpNAc-(1-->2)-β-D-Glcp-(1-->4)] and [branched to β-D-Glcp-(1-->3)] -(1-->5)-Kdo[ branched to Kdop-(2-?)]


Proposed functions

Moracella lipooligosaccharide is a potential virulence factor

Antigenic Nature used to produce antibodies

Whole cells

Carrier Name

nil

Conjugation Method

nil

Antibodies

Mab 8E7

Antibody type and class

IgG3

Assay System

ELISA, immunoblotting, Bacterial adherence assay, Bactericidal assay and immunoelectron microscopy

Cross-reactivity

MAb 8E7 reacted with M. catarrhalis O35E, serotype A and C LOSs but not serotype B LOS

Proposed epitopes

The epitope recognized by MAb 8E7 is directed to a common sequence of either α-GlcNAc-(1-->2)-β-Glc-(1--> at the branch substituting position 4 of the trisubstituted Glc residue or a terminal tetrasaccharide α-Gal-(1-->4)-β-Gal-(1-->4)-α-Glc-(1-->2)-β-Glc-[1--> at the branch substituting position 6 of the trisubstituted Glc residue

Proposed Utility

This Mab had had bactericidal activity. Passive immunization with Mab 8E7 could significantly enhance the clearance of strain O35E from mouse lungs in an aerosol challenge mouse model

Weblink

PubMed Central

External Links